This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Hub Conference 2026 - Hub and Specialty Pharmacy Models East
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Plan Your Visit

Join us at the dynamic Sheraton Philadelphia Downtown for the pharmaceutical industry's most anticipated patient affordability event of the year.

Make a reservation at our venue in Philadelphia for a seamless event experience, bringing patient access professionals under one roof.

Venue

Sheraton Philadelphia Downtown

Sheraton Philadelphia Downtown

201 N, 17th St.

Philadelphia, PA 19103

Hotel Direct Line: +1-215-448-2000

Our hotel block is now closed. Please explore the hotel map for hotel options close to the venue.

PLEASE NOTE: All hotel reservations for this conference should be booked directly with the hotel. Informa Connect does not partner with housing bureaus or third-party agencies for this event and none are authorized to call or contact you on our behalf.

Why Attend?

Engage in thought-provoking discussions, gain valuable industry benchmarks and expand your network with peers and leading experts. Whether you're a newcomer or a seasoned professional, our in-depth sessions offer critical insights into:

  • Evolving patient support strategies to navigate diverse hub models, optimize resources and align patient services with broader organizational goals
  • Harnessing AI, technology and data to enhance patient engagement, streamline operations, deliver personalized support and improve patient adherence and patient satisfaction
  • Adapting to evolving health policy, such as the Inflation Reduction Act (IRA), changes to Medicaid and payer mix shifts, while addressing industry consolidation and copay smoothing challenges
  • Optimizing distribution and financial strategies by evaluating buy-and-bill versus specialty pharmacy models, refining gross-to-net approaches and designing networks that balance access and improve adherence